BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23303224)

  • 1. Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy.
    Verburg FA; Sweeney R; Hänscheid H; Dießl S; Israel I; Löhr M; Vince GH; Flentje M; Reiners C; Samnick S
    Nuklearmedizin; 2013; 52(1):36-42. PubMed ID: 23303224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I; Brandau W; Farmakis G; Samnick S
    Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
    Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
    J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The possibilities of fractionated external beam repeat irradiation of relapsed primary brain tumours: the first Hungarian experience].
    Mangel L; Sipos L; Fedorcsák I; Viola A; Julow J; Bajcsay A; Németh G; Fodor J
    Orv Hetil; 2007 Sep; 148(39):1843-9. PubMed ID: 17890172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
    Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
    Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
    Samnick S; Hellwig D; Bader JB; Romeike BF; Moringlane JR; Feiden W; Kirsch CM
    Nucl Med Commun; 2002 Feb; 23(2):121-30. PubMed ID: 11891465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
    Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
    Koot RW; Habraken JB; Hulshof MC; Paans AM; Bosch DA; Pruim J
    Acta Neurochir (Wien); 2008 Apr; 150(4):345-9. PubMed ID: 18278573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.
    Douglas JG; Stelzer KJ; Mankoff DA; Tralins KS; Krohn KA; Muzi M; Silbergeld DL; Rostomily RC; Scharnhorst J; Spence AM
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):886-91. PubMed ID: 16242251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
    Pöpperl G; Goldbrunner R; Gildehaus FJ; Kreth FW; Tanner P; Holtmannspötter M; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1018-25. PubMed ID: 15877226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
    Boisserie G; Cornu P; Dormont D; Sahel M; Hardiman C; Tep B; Mandin AM; Barret C; Faillot T; Delattre JY; Monjour A; Poisson M; Marsault C; Philippon J; Simon JM; Baillet F; Mazeron JJ
    Bull Cancer Radiother; 1996; 83(3):144-52. PubMed ID: 8977564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
    Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
    Park SS; Chunta JL; Robertson JM; Martinez AA; Oliver Wong CY; Amin M; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):885-92. PubMed ID: 21489704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
    Tralins KS; Douglas JG; Stelzer KJ; Mankoff DA; Silbergeld DL; Rostomily RC; Hummel S; Scharnhorst J; Krohn KA; Spence AM
    J Nucl Med; 2002 Dec; 43(12):1667-73. PubMed ID: 12468518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative hypofractionated radiotherapy in glioblastoma multiforme.
    Arslan M; Karadeniz AN; Aksu G; Güveli M; Fayda M; Doğan AK; Akyüz F
    J BUON; 2006; 11(1):39-42. PubMed ID: 17318950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.
    Reddy K; Gaspar LE; Kavanagh BD; Chen C
    J Med Imaging Radiat Oncol; 2014 Dec; 58(6):714-21. PubMed ID: 24975917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
    Jalali R; Brada M; Perks JR; Warrington AP; Traish D; Burchell L; McNair H; Thomas DG; Robinson S; Johnston DG
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography-guided conformal fast neutron therapy for glioblastoma multiforme.
    Stelzer KJ; Douglas JG; Mankoff DA; Silbergeld DL; Krohn KA; Laramore GE; Spence AM
    Neuro Oncol; 2008 Feb; 10(1):88-92. PubMed ID: 18055860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.